Pediatric home‐based central venous access device dressings: Medical liquid adhesive versus standard care to reduce dressing disruption: The STICKY‐kids RCT protocol

BACKGROUND: Central venous access devices (CVADs) are frequently used in Hospital-At-Home models to facilitate prolonged intravenous treatment for children. Premature CVAD dressing disruption is common and contributes to device failure. This protocol describes a trial evaluating the adjunctive use of medical liquid adhesive at the dressing-skin interface to improve dressing adhesion and maintain dressing integrity. METHODS: This single-site, two-arm, parallel-group, superiority randomized controlled trial undertaken in a children's Hospital-at-Home will evaluate whether adding medical liquid adhesive to standard CVAD dressings, compared with standard dressing alone, reduces dressing disruption. Children aged ≤18 years requiring a CVAD for ≥7 days will be randomized 1:1 to standard dressing plus medical liquid adhesive or standard dressing alone. Dressing integrity will be assessed daily, with dressing-related outcomes assessed after 7 days or following dressing change (whichever occurs first). At each dressing change, participants are eligible for repeat participation, retaining their original randomization. The primary outcome is dressing disruption requiring premature replacement or reinforcement before the scheduled 7-day change. Secondary dressing-related outcomes include dressing dwell-time, skin adverse events, CVAD complications, patient, caregiver, and clinician satisfaction. Secondary outcomes assessed once per participant are healthcare utilization and costs. Analyses will follow the intention-to-treat principle. DISCUSSION: Ensuring the safety and durability of invasive devices beyond the in-hospital setting is an increasing priority in pediatric care. This trial will provide rigorous data to inform the clinical- and cost-effectiveness of the addition of medical liquid adhesive to standard dressings to improve CVAD dressing integrity, supporting care across the hospital-to-home continuum.

Authors

Institutions

Publication Details

Journal
Journal of Hospital Medicine
Published
2026-07-16
DOI
https://doi.org/10.1002/jhm.70376
Primary Topic
Central Venous Catheters and Hemodialysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pediatric home‐based central venous access device dressings: Medical liquid adhesive versus standard care to reduce dressing disruption: The STICKY‐kids RCT protocol

Tricia M. Kleidon, Mari De La Rosa Takashima, Nicole M. Marsh, Robert S. Ware et al.
Journal of Hospital Medicine
Central Venous Catheters and Hemodialysis
article

Pediatric home‐based central venous access device dressings: Medical liquid adhesive versus standard care to reduce dressing disruption: The STICKY‐kids RCT protocol

Tricia M. Kleidon, Mari De La Rosa Takashima, Nicole M. Marsh, Robert S. Ware, Victoria Gibson, Amanda Judith Ullman
article en

Abstract

BACKGROUND: Central venous access devices (CVADs) are frequently used in Hospital-At-Home models to facilitate prolonged intravenous treatment for children. Premature CVAD dressing disruption is common and contributes to device failure. This protocol describes a trial evaluating the adjunctive use of medical liquid adhesive at the dressing-skin interface to improve dressing adhesion and maintain dressing integrity. METHODS: This single-site, two-arm, parallel-group, superiority randomized controlled trial undertaken in a children's Hospital-at-Home will evaluate whether adding medical liquid adhesive to standard CVAD dressings, compared with standard dressing alone, reduces dressing disruption. Children aged ≤18 years requiring a CVAD for ≥7 days will be randomized 1:1 to standard dressing plus medical liquid adhesive or standard dressing alone. Dressing integrity will be assessed daily, with dressing-related outcomes assessed after 7 days or following dressing change (whichever occurs first). At each dressing change, participants are eligible for repeat participation, retaining their original randomization. The primary outcome is dressing disruption requiring premature replacement or reinforcement before the scheduled 7-day change. Secondary dressing-related outcomes include dressing dwell-time, skin adverse events, CVAD complications, patient, caregiver, and clinician satisfaction. Secondary outcomes assessed once per participant are healthcare utilization and costs. Analyses will follow the intention-to-treat principle. DISCUSSION: Ensuring the safety and durability of invasive devices beyond the in-hospital setting is an increasing priority in pediatric care. This trial will provide rigorous data to inform the clinical- and cost-effectiveness of the addition of medical liquid adhesive to standard dressings to improve CVAD dressing integrity, supporting care across the hospital-to-home continuum.

Journal of Hospital Medicine
Griffith University (AU), The University of Queensland (AU), Royal Brisbane and Women's Hospital (AU), Children’s Health Queensland Hospital and Health Service (AU)
Openalex Percentile: Top 6%
Central Venous Catheters and Hemodialysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.